- $2.65bn
- $2.94bn
- $906.54m
- 88
- 33
- 77
- 72
Annual income statement for Perficient, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 566 | 612 | 761 | 905 | 907 |
Cost of Revenue | |||||
Gross Profit | 211 | 231 | 292 | 352 | 332 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 510 | 561 | 684 | 761 | 769 |
Operating Profit | 55.3 | 50.7 | 76.9 | 144 | 138 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 47.9 | 40.3 | 62.5 | 141 | 136 |
Provision for Income Taxes | |||||
Net Income After Taxes | 37.1 | 30.2 | 52.1 | 104 | 98.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 37.1 | 30.2 | 52.1 | 104 | 98.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 37.1 | 30.2 | 52.1 | 107 | 98.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.17 | 1.12 | 2.29 | 2.98 | 2.71 |